Specialty Dosage Drugs

Jun 29, 2017
By Pharmaceutical Technology Editors
The agency announced a plan to eliminate its existing orphan designation request backlog.
Jun 13, 2017
Equipment and Processing Report
At an industry seminar hosted by Leistritz Extrusion, experts explained the use of extrusion equipment to mix polymeric excipients with APIs for solubility enhancement and for multifunctional and specialty dosage forms, including implants.
Jun 13, 2017
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
Aptar now manufactures its child-resistant pump, designed to meet US CPC requirements, at its facility in Congers, New York.
Jun 02, 2017
Pharmaceutical Technology
Follow guidelines for E&L studies of an orally inhaled and nasal drug product formulation in its delivery device.
May 15, 2017
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
Catalent has been working together with Lexicon to develop the drug formulation of Xermelo, which has now been approved by FDA for the treatment of carcinoid syndrome diarrhea.
Apr 25, 2017
Sponsored Content
Catalent combines its formulation expertise, manufacturing excellence and particle size reduction technologies to provide a broad range of solutions in the development of inhalation and nasal drug products.
Apr 12, 2017
By Pharmaceutical Technology Editors
The project will foster the translation of nanomedicine applications for the treatment of cardiovascular diseases.
Apr 03, 2017
By Pharmaceutical Technology Editors
GW Pharmaceuticals plans to submit a regulatory filing to FDA and EMA following two positive Phase III trials of Epidiolex in patients with Lennox-Gastaut Syndrome.
Mar 24, 2017
By Pharmaceutical Technology Editors
The agency recommended six drugs for approval in March 2017 including treatments for neuroblastoma, heart failure, and more.
Feb 24, 2017
By Pharmaceutical Technology Editors
The agency’s CHMP recommended conditional marketing authorization for the hormone replacement therapy for the treatment of chronic hypoparathyroidism.
native1_300x100
lorem ipsum